factor for developing heart disease. He received his Ph.D. in chemistry from the University of Kanpur, India. He obtained his post-doctoral training at the University of Texas Medical Branch, Galveston, Texas.
Edmund A. C. Crouch, Ph.D., is a senior scientist with Cambridge Environmental Inc. in Cambridge, Massachusetts. He has published widely in the areas of risk assessment, and presentation and analysis of uncertainties. He has co-authored a major text in risk assessment, Risk/Benefit Analysis. Dr. Crouch serves as an expert advisor to various local and national agencies concerned with public health and the environment, and has served on a number of National Academy of Sciences committees, including the Committee on Health Effects of Waste Incineration. Dr. Crouch received his Ph.D. in High Energy Physics from Cambridge University.
Francesca Dominici, Ph.D., is a professor of biostatistics in the Harvard School of Public Health at Harvard University. Dr. Dominici’s research has focused on the interface between the methodological development of hierarchical models and their applications to multi-level data. She has extensive experience on the development of statistical methods and their applications to clinical trials, toxicology, biology, and environmental epidemiology. Her main research interest is in the development of statistical models and the conduct of epidemiological studies to estimate the health effects of air pollution. She has served on a number of National Academies’ committees including the Committee on Gulf War and Health: Review of the Medical Literature Relative to Gulf War Veterans’ Health; the Committee to Assess Potential Health Effects from Exposures to PAVE PAWS Low-Level Phased-array Radiofrequency Energy; and the Committee on The Utility of Proximity-Based Herbicide Exposure Assessment in Epidemiologic Studies of Vietnam Veterans. Dr. Dominici received her Ph.D. in statistics at the University of Padua, Italy.
Ellen A. Eisen, Sc.D., is an adjunct professor of environmental health sciences and epidemiology at the School of Public Health at the University of California, Berkeley, and environmental health at Harvard School of Public Health. Her research focuses on methods for modeling exposure-response in occupational cohort studies. She has studied respiratory, cancer and cardiovascular outcomes in relation to a wide variety of occupational exposures, including silica, cotton dust, endotoxin, welding fumes, and metalworking fluids. Her early studies of longitudinal decline in pulmonary function identified high test variability of FEV1 as a biomarker of impaired lung function and the standard exclusion of nonreproducible tests as a source of selection bias. She has published many papers on cancer incidence and mortality in relation to oil-based metalworking fluids in autoworkers. Dr. Eisen has served on numerous NRC and IOM committees, including the Committee on Asbestos: Selected Health Effects and the Committee on the Health Effects of Mustard Gas and Lewisite. Dr. Eisen earned her Sc.D. in biostatistics and occupational health from the Harvard School of Public Health.
Mary A. Fox, Ph.D., M.P.H., is an assistant professor in the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health. Her research is focused on developing cumulative risk assessment to inform public-health decision making. Dr. Fox has applied cumulative-risk methods in numerous community health assessments. Her current research is directed at national-level decision-making and includes the relationship between exposure to a mixture of nephrotoxic metals and renal function and applications of risk assessment to policy evaluation. Dr. Fox earned her M.P.H. from the University of Rochester School of Medicine and Dentistry and her Ph.D. from the Johns Hopkins Bloomberg School of Public Health.
Mark W. Frampton, M.D., is a professor of medicine and environmental medicine at the University of Rochester School of Medicine and Dentistry. He is also the medical director of the Pulmonary Function Laboratory at the University of Rochester Medical Center. Dr. Frampton is board certified in Internal Medicine and Pulmonary Diseases, and his research focuses on human clinical studies of the health effects of gaseous and particulate air pollution. He has served as a member on the external scientific advisory committees of the Southern California and Harvard Particulate Matter Centers, and as a consultant for the California Air Resources Board. Dr. Frampton received his M.D. from the New York University School of Medicine.